Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3634587 | 0.85 | ALDH1A1 (0.31) | — | |
| SCHEMBL124322 | 0.83 | ALDH1A1 (0.49) | CTSK | |
| SCHEMBL19105133 | 0.81 | ALDH1A1 (0.43) | CTSK | |
| SCHEMBL7746437 | 0.81 | TSHR (0.32) | — | |
| SCHEMBL14065277 | 0.81 | — | — | |
| SCHEMBL13294290 | 0.80 | CTSK (0.31) | CTSK | |
| SCHEMBL14256290 | 0.79 | TSHR (0.31) | CTSK | |
| SCHEMBL6765811 | 0.79 | TSHR (0.31) | CTSK | |
| SCHEMBL18802085 | 0.79 | CYP3A4 (0.35) | CTSK | |
| SCHEMBL11990066 | 0.79 | TDP1 (0.31) | CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10431825-B2 | Negative electrode for secondary battery, method for manufacturing same, and secondary battery using same | NEC CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20160172677-A1 | NEGATIVE ELECTRODE FOR SECONDARY BATTERY, METHOD FOR MANUFACTURING SAME, AND SECONDARY BATTERY USING SAME | NEC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10431825-B2 | Negative electrode for secondary battery, method for manufacturing same, and secondary battery using same | CACNA2D3, CACNA2D2, CACNA2D1 | CTSK 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.